Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Liabilities and Shareholders Equity (2016 - 2025)

CV Sciences' Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $7.0 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 12.17% to $7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.7 million, a 11.89% decrease, with the full-year FY2025 number at $7.0 million, down 12.17% from a year prior.
  • Liabilities and Shareholders Equity hit $7.0 million in Q4 2025 for CV Sciences, roughly flat from $7.0 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for CVSI hit a ceiling of $30.7 million in Q1 2021 and a floor of $7.0 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $13.3 million across 5 years, with a median of $9.8 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: tumbled 43.34% in 2022 and later dropped 8.33% in 2025.
  • Tracing CVSI's Liabilities and Shareholders Equity over 5 years: stood at $18.1 million in 2021, then decreased by 29.5% to $12.7 million in 2022, then dropped by 27.76% to $9.2 million in 2023, then dropped by 13.84% to $7.9 million in 2024, then decreased by 12.17% to $7.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CVSI at $7.0 million in Q4 2025, $7.0 million in Q3 2025, and $8.0 million in Q2 2025.